NCT02035345 Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment Status TERMINATED Phase PHASE4
NCT02033551 A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT02032277 A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer Status COMPLETED Phase PHASE3
NCT02031250 Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer Status COMPLETED Phase PHASE2
NCT02026921 A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02023710 Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma Status UNKNOWN Phase PHASE2
NCT02018861 A Phase 1/2, Open-Label, Dose Escalation, Safety and Tolerability Study of INCB050465 and Itacitinib in Subjects With Previously Treated B-Cell Malignancies (CITADEL-101) Status COMPLETED Phase PHASE1/PHASE2
NCT02017964 Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma Status COMPLETED Phase PHASE2
NCT02013453 A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer Status WITHDRAWN Phase PHASE2
NCT02004093 A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer Status COMPLETED Phase PHASE2
NCT02003209 Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT01998919 A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer. Status COMPLETED Phase PHASE2
NCT01995188 A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer Status COMPLETED Phase PHASE1
NCT01993810 Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer Status COMPLETED Phase PHASE3
NCT01987232 Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01982955 Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT) Status COMPLETED Phase PHASE1/PHASE2
NCT01970722 Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01966003 Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01964391 A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer Status COMPLETED Phase PHASE3